CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
107 hedge funds and large institutions have $627M invested in Cymabay Therapeutics in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% more funds holding
Funds holding: 80 → 107 (+27)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
Holders
107
Holding in Top 10
5
Calls
$1.5M
Puts
$447K
Top Buyers
| 1 | +$42.3M | |
| 2 | +$22.1M | |
| 3 | +$15.8M | |
| 4 |
Millennium Management
New York
|
+$14.2M |
| 5 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
+$12.5M |
Top Sellers
| 1 | -$11.3M | |
| 2 | -$7.14M | |
| 3 | -$5.53M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.21M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$1.95M |